# FDA 483 - Revance Therapeutics, Inc. - February 27, 2025

Source: https://www.globalkeysolutions.net/records/483/revance-therapeutics-inc/1e4e8ce1-6bdf-4c1a-9d3f-7df594b9a26a

> FDA 483 for Revance Therapeutics, Inc. on February 27, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Revance Therapeutics, Inc.
- Inspection Date: 2025-02-27
- Product Type: drugs
- Office Name: San Francisco District Office

## Related Documents

- [EIR - 2021-07-02](https://www.globalkeysolutions.net/records/eir/revance-therapeutics-inc/1510d06c-9272-4e0c-a5da-eeffa081a9f1)
- [CRL - Unknown Date](https://www.globalkeysolutions.net/records/crl/revance-therapeutics-inc/04992544-f520-4579-9861-784ea9ce1560)

## Related Officers

- [Philip F. Istafanos](https://www.globalkeysolutions.net/people/philip-f-istafanos/c2fcfe52-1070-4551-bffc-f8bcfad5b30b)
- [Team Biologics Staff](https://www.globalkeysolutions.net/people/linda-thai/f4d9a1c3-e5e8-4f13-8abe-e1f1e597c8f8)

Company: https://www.globalkeysolutions.net/companies/revance-therapeutics-inc/33277fcf-5886-406e-8332-bc85057ba4bc

Office: https://www.globalkeysolutions.net/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df